Navigation Links
HealthWarehouse.com Reports 38% Year-Over-Year Revenue Growth in the First Quarter 2012
Date:9/5/2012

CINCINNATI, Sept. 5, 2012 /PRNewswire/ -- HealthWarehouse.com, Inc. (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, today announced its financial results for the first quarter ended March 31, 2012.

In the first quarter of 2012, the Company's quarterly net sales increased to $3,153,607 from $2,284,552, up 38% compared to the same period in 2011. 

Selling, general and administrative expenses (SG&A) increased by $730,780 in the first quarter of 2012 compared to the same period in 2011.  Net loss in the first quarter of 2012 increased to $1,550,312, as compared with a net loss of $1,071,279 for the same period in 2011. The increase in SG&A expenses and net loss was due primarily to the expansion of resources to handle growth of the Company's prescription sales.

"We are pleased with the growth we continue to see with our business," said Lalit Dhadphale, President and CEO of HealthWarehouse.com. "We remain focused on execution and are excited by the solid sales we've witnessed from the recent generic launches of Plavix® and Lipitor®. We expect this momentum to continue with the recent releases of generic Actos® and Singulair®. Additionally, we intend to take increasing market share over the next few quarters by expanding our sales channels and exceeding customer expectations."

About HealthWarehouse.com, Inc.

HealthWarehouse.com, Inc. (OTC: HEWA) is a trusted VIPPS-accredited retail mail-order pharmacy based in the Cincinnati area.  HealthWarehouse.com offers more than 300 prescription drugs for $3.50 with 100% FREE shipping and is a three-time consecutive winner of the BizRate Circle of Excellence Award for outstanding customer satisfaction and service. With a mission to provide affordable healthcare to every American by eliminating inefficiencies in the drug distribution chain, HealthWarehouse.com has become the leading online pharmacy in the United States. HealthWarehouse.com is licensed in all 50 states and DC, and only sells drugs which are FDA-approved and legal for sale in the United States.  Visit HealthWarehouse.com online at http://www.HealthWarehouse.com.

Actos® is a registered trademark of Takeda Pharmaceutical Company Limited.

Lipitor® is a registered trademark of Pfizer Corporation.

Plavix® is a registered trademark of Sanofi-Aventis.

Singulair® is a registered trademark of Merck & Co., Inc.


'/>"/>
SOURCE HealthWarehouse.com, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HealthWarehouse.com and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
2. HealthWarehouse.com Reports 82% Year-Over-Year Revenue Growth
3. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
4. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
5. MGC Diagnostics Corporation Reports Third Quarter Fiscal Year 2012 Operating Results
6. Groupe Athena Inc., (OTC: GATA) Reports Audited Financials, Announces Record Revenue & Profits
7. China Nepstar Chain Drugstore Reports Second Quarter 2012 Financial Results
8. China Kanghui Holdings Reports Second Quarter 2012 Financial Results
9. Concord Medical Reports Second Quarter 2012 Financial Results
10. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
11. Organovo Reports Q2 2012 Financial Results, Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology:
(Date:2/6/2016)... IL (PRWEB) , ... February 06, 2016 , ... ... recovery phases of eating disorder treatment helps to reduce the frequency and level ... of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe ... signed a joint enrollment and degree completion agreement. The agreement, which begins ... degrees at FHU|Dickson. , The agreement allows students to be jointly admitted ...
(Date:2/5/2016)... ... ... The American public tends to feel uncomfortable about drinking recycled waste water ... well water. The recent experience with lead contaminated water in Flint, Michigan, according to ... increasing public acceptance of recycled waste water as drinking water. , The Flint ...
(Date:2/5/2016)... , ... February 05, 2016 , ... At its annual ... Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds former ... the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat has ...
Breaking Medicine News(10 mins):